Antioxidative defence capacity in sporadic Alzheimer's disease and in transgenic mice overexpressing amyloid-beta

被引：0
|
作者：
Schüssel, K
Leutner, S
Cairns, NJ
Czech, C
Pradier, L
Müller, WE
Eckert, A
机构：
[1] Univ Frankfurt, Dept Pharmacol, Bioctr, D-6000 Frankfurt, Germany
[2] Inst Psychiat, MRC, Alzheimers Dis Bank, London, England
[3] Hoffmann La Roche Ag, CNS Res, CH-4070 Basel, Switzerland
[4] Aventis Pharma, Res & Dev, F-94403 Vitry Sur Seine, France
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2003年 / 367卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
335
引用
收藏
页码：R87 / R87
页数：1
相关论文
共 50 条
  • [31] Imaging of Amyloid-Beta Deposits in the Postmortem Retina in Alzheimer's Disease
    Campbell, M. C. W.
    Gowing, L. J. F.
    Choi, Y.
    Leonenko, Z.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [32] Clearance of amyloid-beta in Alzheimer's disease: progress, problems and perspectives
    Wang, Yan-Jiang
    Zhou, Hua-Dong
    Zhou, Xin-Fu
    DRUG DISCOVERY TODAY, 2006, 11 (19-20) : 931 - 938
  • [33] Clusterin in Alzheimer’s disease: a player in the biological behavior of amyloid-beta
    Xiang Li
    Yifei Ma
    Xu Wei
    Yanpeng Li
    Huijuan Wu
    Jianhua Zhuang
    Zhongxin Zhao
    Neuroscience Bulletin, 2014, 30 : 162 - 168
  • [34] Plasma Amyloid-Beta Levels in Korean Patients with Alzheimer's Disease
    Cho, Sun Young
    Kang, So Young
    Lee, Woo In
    CLINICAL LABORATORY, 2016, 62 (08) : 1591 - 1593
  • [35] Failure of elimination of amyloid-beta from the brain in Alzheimer's disease
    de Silva, Prasanna
    Carare, Roxana O.
    Weller, Roy O.
    PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2008, 12 (04) : 6 - 10
  • [36] Amyloid-beta protein related treatment strategies in Alzheimer's disease
    Dodel, R
    EUROPEAN PSYCHIATRY, 2004, 19 : 102S - 102S
  • [37] Amyloid-beta peptide and tau protein crosstalk in Alzheimer's disease
    Roda, Alejandro R.
    Serra-Mir, Gabriel
    Montoliu-Gaya, Laia
    Tiessler, Lidia
    Villegas, Sandra
    NEURAL REGENERATION RESEARCH, 2022, 17 (08) : 1666 - 1674
  • [38] Amyloid-beta and tau proteins as biochemical markers of Alzheimer's disease
    Sobów, T
    Flirski, M
    Liberski, PP
    ACTA NEUROBIOLOGIAE EXPERIMENTALIS, 2004, 64 (01) : 53 - 70
  • [39] Prion Protein Interaction with Amyloid-beta Oligomers of Alzheimer's Disease
    Strittmatter, Stephen M.
    Nygaard, Haakon
    Gimbel, David
    Gunther, Erik
    Um, Ji-Won
    Lauren, Juha
    Coffey, Erin
    Gimbel, Zachary
    PRION, 2010, 4 (03) : 108 - 108
  • [40] Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer’s disease
    Maria Luisa Moro
    Andrew Stephen Phillips
    Katie Gaimster
    Christian Paul
    Amritpal Mudher
    James A. R. Nicoll
    Delphine Boche
    Acta Neuropathologica Communications, 6
12345